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INTRODUCTION
Emerin and lamins are members of the intermediate fila-
ment protein family, and they are major components of the
nuclear envelope. Mutations in the emerin gene cause X-
linked recessive (XR) Emery-Dreifuss muscular dystrophy
(1, 2) (EDMD: MIM 310300).
Mutations in the lamin A/C (LMNA) gene, encoding lamins
A and C by alternative splicing, have been found to cause at
least four different kinds of genetic disorders; autosomal dom-
inant (AD) Emery-Dreifuss muscular dystrophy (3) (EDMD2:
MIM 181350); limb-girdle muscular dystrophy type 1B (4)
(LGMD1B; MIM 159001); dilated cardiomyopathy type 1A
(5) (CMD1A; MIM 115200); and familial partial lipodystro-
phy (6) (FPLD; MIM 151660).
Among these genetic disorders, three disorders, XR EDMD,
AD EDMD2 and LGMD1B, present with both cardiac and
skeletal manifestations, which include cardiac dysrhythmias,
late-onset cardiomyopathy, slowly progressive skeletal myopa-
thy and contractures of the neck, elbows, and ankles. In par-
ticular, XR EDMD and AD EDMD2 share clinically undis-
tinguishable features (7).
In these three disorders, cardiac dysrhythmias including
AV block, bradycardia, atrial fibrillation, and characteristic
atrial standstill often lead to syncope and sudden cardiac death.
Therefore, early diagnosis and implantation of a pacemaker
are life saving. Here, we report three cases of EDMD, EDMD2,
and LGMD1B diagnosed by clinical findings and genetic
analyses. These three patients are the first cases of EDMD,
EDMD2 and LGMD1B, respectively, reported in Korea.
MATERIALS AND METHODS
Three patients were examined at regular intervals over a
period of three to five years by at least one of the authors. The
diagnosis of these patients was made on the basis of clinical
symptoms, family histories, physical as well as neurological
examinations, cardiologic investigations including 12-lead
electrocardiography (ECG), ambulatory ECG monitoring,
electrophysiologic study and echocardiography, electromyo-
graphy (EMG), laboratory studies of muscle enzymes, and
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Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in
Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle
Muscular Dystrophy Type 1B
Emery-Dreifuss muscular dystrophy (EDMD) and limb-girdle muscular dystrophy
type 1B (LGMD1B) are characterized by cardiac dysrhythmias, late-onset cardiomyo-
pathy, slowly progressive skeletal myopathy and contractures of the neck, elbows
and ankles. The causative mutation is either in the emerin gene (X-linked recessive
EDMD) or lamin A/C gene (autosomal dominant EDMD2 or LGMD1B). We report
three cases of EDMD, EDMD2 and LGMD1B. A 14-yr-old boy showed limitation of
cervical flexion and contractures of both elbows and ankles. Sinus arrest with junc-
tional escape beats was noted. He was diagnosed as X-linked recessive EDMD
(MIM 310300). A 28-yr-old female showed severe wasting and weakness of hume-
roperoneal muscles. Marked limitation of cervical flexion and contractures of both
elbows and ankles were noted. Varying degrees of AV block were noted. She was
diagnosed as autosomal dominant EDMD2 (MIM 181350). A 41-yr-old female had
contractures of both ankles and limb-girdle type muscular dystrophy. ECG revealed
atrial tachycardia with high grade AV block. She was diagnosed as autosomal domi-
nant LGMD1B (MIM 159001). Cardiac dysrhythmias in EDMD and LGMD1B include
AV block, bradycardia, atrial tachycardia, atrial fibrillation, and atrial standstill, causing
sudden death necessitating pacemaker implantation. Cardiologists should know
about these unusual genetic diseases with conduction defects, especially in young
adults.
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muscle biopsy. Information on deceased family members as
well as on other family members who were suspected to be
affected was obtained from probands. Genetic analyses were
performed to identify mutations in the LMNA and emerin
genes. The genetic analysis of mutations in the lamin gene
(EDMD2, LGMD1B) has been reported previously (8), and
parts of clinical findings of case 1 and 2 were described else-
where (9, 10).
RESULTS
Clinical and pathologic findings of three patients are shown
in Table 1. Cardiac findings are summarized in Table 2.
Case 1 (XR EDMD: MIM 310300)
A 14-yr-old boy presented with a gait disturbance. At age
1, contractures of the Achilles tendon were noted and con-
tractures of the elbows were observed at age 9. On physical
examination, the patient showed contractures of both ankles,
elbow joints and limitation of neck flexion (Fig. 1A). He also
showed a mild waddling and toe gait. He had weakness of
the proximal upper limbs. Both proximal and distal weakness
was present in the lower limbs. No deep tendon reflexes could
be elicited at both ankles and elbow joints. A family history
revealed that his maternal uncle had abnormal clinical features
similar to those of the patient (Fig. 2A).
Serum creatine kinase (CK) activity was 481 IU/L (refer-
ence interval; 24-204 IU/L). Serum lactate dehydrogenase
(LDH) level was 659 IU/L (reference interval; 240-480 IU/L).
EMG revealed abnormal spontaneous activities, short dura-
tion low amplitude motor units and short duration polypha-
sic motor unit potentials (MUP) and early recruitment pat-
terns on volition, suggesting myogenic disorder.
Echocardiographic findings showed normal LV systolic func-
tion and dilated right atrium and right ventricle. ECG showed
sinus arrest with junctional escape rhythm (Fig. 3A). Ambu-
latory ECG monitoring revealed episodes of atrial fibrillation
with complete AV block and junctional escape rhythm (Fig.
4A). Asystole up to 4 sec was observed. In an electrophysio-
logic study, no electrical signal was noted in the upper right
atrium (Fig. 5). Junctional escape beats were noted. A VVI
type permanent pacemaker was implanted.
Genetic analysis revealed a mutation in exon 2 of the emerin
gene by deletion of the C nucleotide at position 397 of the
genomic DNA sequence.
Case 2 (AD EDMD2: MIM 181350)
A 28-yr-old female presented to the cardiology department
complaining of intermittent dizziness and palpitation. Exam-
ination showed marked wasting and weakness of the shoulder
girdle, proximal arm, and the proximal and distal leg mus-
Variables
XR EDMD
(Case 1)
AD EDMD2
(Case 2)
AD LGMD1B
(Case 3)
Sex Male Female Female
Age at examination (yr) 14 28 41
Age at onset of muscular 1 3 15
symptoms (yr)
Wasting or weakness
Upper girdle Yes Yes Yes
Arm No Yes Yes
Forearm-hand No Yes No
Pelvic girdle Yes Yes Yes
Thigh Yes Yes Yes
Leg Yes Yes Yes
Contractures
Neck Yes Yes No
Elbows Yes Yes No
Ankles Yes Yes Yes
Tendon reflexes Absent Absent Absent
CK (24-204 IU/L) 481 195 55
LDH (240-480 IU/L) 659 664 618
EMG Myopathic Myopathic Myopathic
Muscle biopsy Myopathic Myopathic Myopathic
Table 1. Clinical and pathological findings
CK, creatine kinase; LDH, lactate dehydrogenase; EMG, electromyo-
graphy.
Variables
XR EDMD
(Case 1)
AD EDMD2
(Case 2)
AD LGMD1B
(Case 3)
Age at detection of cardiac symptoms (yr) 14 28 39
First symptoms Palpitation, Exertional dyspnea Palpitation, Dizziness Syncope, Exertional dyspnea
Stroke -- +
Conduction system disease Atrial standstill I, II AV-block Atrial standstill
Features of rhythm Junctional rhythm Sinus rhythm Junctional rhythm
Permanent pacemaker + + +
Increased end diastolic diameters RV, RA - LV, LA, RA
Left ventricular ejection fraction (%) 60 63 40
Diastolic dysfunction - + -
Myocardial hypertrophy -- -
Table 2. Cardiac findings
AV, atrioventricular; LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle.cles. She developed progressive muscle wasting of the lower
extremities and difficulty in walking during her teens. She also
presented with marked limitation of cervical flexion, contrac-
ture of the both elbows limiting arm extension, and contrac-
ture of the Achilles tendon causing equinus deformities of
the feet (Fig. 1B). The deep tendon reflexes of the lower legs
were absent. Her elder sister died of unknown causes at 28 yr
of age with similar clinical features (Fig. 2B).
Serum CK level was 195 IU/L and serum LDH level was
664 IU/L. EMG revealed increased insertional activities, short
duration polyphasic MUP, and an early recruitment or dec-
reased interference pattern, suggesting a chronic myogenic
disorder. Biopsy of the left gastrocnemius muscle revealed
findings compatible with muscular dystrophy (Fig. 6A). Myo-
fibers are reduced and replaced by fibroadipose tissues. There
are marked variations in fiber size associated with atrophic
or hypertrophic myofibers, fiber splitting and an increase of
internal nuclei. Fiber necrosis and infiltration of inflamma-
tory cells were not present.
Echocardiography showed normal LV cavity size and nor-
mal LV systolic function, but restrictive physiology was noted.
ECG showed sinus pause and first degree AV block (Fig. 3B).
Slow non-sustained atrial tachycardia at a rate of 120 beats/
min with high grade AV block was noted by ambulatory ECG
monitoring (Fig. 4B). A VVI type permanent pacemaker was
implanted due to risk of sudden death associated with high
degree AV block.
Genetic analysis showed a G to A transition in exon 4 region
of the lamin A/C (LMNA) gene (c.746G>A: R249Q).
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Fig. 1. Photographs of each patient. (A) XR EDMD patient (case 1)
showing flexion contractures of both elbows and Achilles tendons.
(B) AD EDMD2 patient (case 2) showing marked muscular atrophy
of upper and lower extremities with flexion contractures of both
elbows and Achilles tendons. The patient keeps her heel off the
floor with equinus deformities of the feet. (C) LGMD1B patient (case
3) shows peroneal dystrophy with Achilles tendon contractures.
Equinus deformity of the right foot is more severe than the left one.286 J.-S. Hong, C.-S. Ki, J.-W. Kim, et al.
Case 3 (AD LGMD1B: MIM 159001)
A 41-yr-old female presented with ankle contractures start-
ing in her early teens. The contractures were more severe on
the right side (Fig. 1C). She had gait disturbance and diffi-
culty climbing stairs due to ankle contractures as well as prox-
imal leg weakness. A neurological evaluation revealed limb-
girdle muscle weakness, particularly in the proximal arms
and thighs. The deep tendon reflexes of both ankle joints were
absent. At age 39, she experienced loss of consciousness for
30 min. One year later, transient right hemiparesis developed.
Two elder sisters died at 20 and 38 yr of age, due to heart
problems. Another sister had a clinical picture similar to that
of the patient (Fig. 2C).
Serum CK level was 55 IU/L and serum LDH level was
618 IU/L. EMG revealed low amplitude short duration poly-
phasic MUP on volition and decreased interference patterns,
compatible with chronic myogenic disorder. A muscle biopsy
from the quadriceps muscle showed an increase in the num-
ber of internal nuclei, mild variation in the muscle fiber diam-
eter, scattered small-angulated myofibers and fatty ingrowth
(Fig. 6B). There was marked atrophy of type 1 fibers with a
predominance of type 2 fibers (Fig. 6C, D).
Echocardiographic findings showed dilated cardiomyopa-
thy. The ejection fraction of the left ventricle was 40% and
end diastolic diameter of the left ventricle was 58 mm. Seri-
al checks of ECG revealed progression of abnormalities from
sinus bradycardia, first-degree AV block, to episodes of parox-
ysmal atrial tachycardia. Her final ECG (Fig. 3C) and ambu-
latory ECG monitoring showed atrial tachycardia and high
grade (3:1, 4:1) AV block (Fig. 4C). A VVI type permanent
pacemaker was implanted.
This patient has a G to T transversion in exon 6 region of
LMNA gene (c.1130G>T: R377L).
DISCUSSION
The disorders manifested with both cardiac involvement
Fig. 3. 12-lead ECG of EDMD (A), AD EDMD2 (B) and LGMD1B
(C). (A) The ECG shows sinus arrest with junctional escape rhythm
at a heart rate of 40 beats per minute. (B) The ECG shows left axis
deviation, left anterior hemiblock, first-degree atrioventricular block,
and sinus pause. (C) The ECG shows atrial fibrillation with ST-T
changes.
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Fig. 2. Pedigrees of the families with XR EDMD (A), AD EDMD2 (B)
and LGMD1B (C). Squares indicate male family members, circles
female family members and symbols with a slash mark deceased
family members. Open symbols indicate unaffected family mem-
bers, filled symbols indicate the presence of neuromuscular and
cardiac symptoms, and shaded symbols indicate family members
who are or were probably affected. Arrows represent proband. B
and C from reference 8.
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C
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and skeletal muscular dystrophy can be categorized into two
groups. The first group is characterized by muscular dystro-
phy with predominant cardiomyopathy, which includes Du-
chenne or Becker’s muscular dystrophy. The second group is
characterized by muscular dystrophy with predominant car-
diac conduction disturbances, which includes EDMD and
LGMD1B. Both EDMD and LGMD1B are caused by the
mutations of nuclear envelope proteins, i.e. emerin and lamin,
respectively. EDMD consists of two diseases, XR emerin gene
mutation (EDMD) and AD lamin gene mutation (EDMD2).
Even though they are caused by mutations of different genes,
they show very similar clinical features. LGMD1B is an allelic
variant of the lamin gene mutation, which has an overlapping
phenotype with EDMD (4).
It is not well-known why defects of nuclear envelope pro-
teins show cardiac and skeletal myopathy and involvement
of conduction systems in the heart. Emerin is localized at the
inner nuclear membrane in various tissues by its transmem-
brane domain at the C-terminus (1). Amino acid sequence
similarities and cellular location suggested that emerin is a
member of nuclear lamina-associated protein (LAP) family.
Cartegni et al. (11) proposed a general role for emerin in mem-
brane anchorage to the cytoskeleton. In heart, its specific local-
ization to desmosomes and fasciae adherentes of the interca-
lated discs could account for the characteristic conduction
defects described in patients with EDMD. A deficiency of
emerin in immunofluorescent staining of skeletal and cardiac
muscles from EDMD patients was observed (2). The lamin
A/C (LMNA) gene encodes two proteins of the nuclear lamina,
lamins A (664 amino acids) and C (572 amino acids) produced
by alternative splicing (5). Like emerin, lamins A and C are
components of the nuclear envelope but are located in the
lamina, a multicentric structure associated with the nucleo-
plasmic surface of the inner nuclear membrane. According
to Hutchinson et al. (12), the nuclear membrane damage and
lamina fragility could develop into physical cell disruption
leading to myocyte death and tissue damage. In cardiac mus-
cle, the loss of individual mononucleated myocytes is cumu-
lative and eventually leads to atrioventricular block and heart
failure when the number of affected myocytes is sufficient to
cause the phenotype. Therefore, the extension of myocyte
damage in nodal versus left ventricular myocardium could
partly explain the earlier occurrence of atrioventricular block
than left ventricular dysfunction (13).
The classical phenotype of EDMD is characterized by the
clinical triad of early contractures of the Achilles tendons,
elbows and postcervical muscles and slowly progressive mus-
cle wasting and weakness with a distinctive humeroperoneal
distribution in the early stages of the disease, cardiomyopa-
thy with life threatening conduction defects (14). LGMD1B
is characterized by a slowly progressive weakness of the proxi-
mal muscles, mild joint contractures, age-related atrioventric-
ular cardiac conduction disturbances and dilated cardiomy-
opathy (15). Phenotypes of LGMD1B overlap with EDMD.
Although the clinical feature of muscle involvement in both
XR EDMD and AD EDMD2 are quite similar, the pattern
of muscular involvement in AD EDMD2 is extremely vari-
able. In XR EDMD, the first symptoms are generally con-
tractures, weakness and difficulty in running in patients with
AD EDMD2 and are usually presented between 3 and 6 yr
of age, and the contractures generally appeared afterwards.
Some AD EDMD2 patients lose ambulation, unlike patients
with XR EDMD in whom loss of ambulation is very rare.
Therefore, muscle weakness and disease course tend to be more
A
B
C
Fig. 4. Findings of ambulatory ECG monitorings of EDMD (A), AD
EDMD2 (B) and LGMD1B (C). (A) Atrial fibrillation with complete
AV block and junctional escape rhythm. (B) Slow nonsustained
atrial tachycardia at a rate of 120 beats per minute with high grade
AV block. (C) Atrial tachycardia and high grade (3:1, 4:1) AV block
with the longest R-R interval of 2.06 sec.
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Fig. 5. Findings of electrophysiologic study in a patient with XR
EDMD (case 1). Electrophysiologic study shows no electrical sig-
nal in the right upper atrium. Junctional escape beats are noted.
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16-STIN 1severe in AD EDMD2 than XR EDMD (7). In LGMD1B,
symmetrical weakness starts in the proximal lower limb mus-
cles, and gradually the upper limb muscles also become affect-
ed. Early contractures of the spine were absent, and contrac-
tures of the elbows and the Achilles tendons were either min-
imal or late, distinguishing this disorder from EDMD (15).
The findings of muscular involvement in our cases are com-
patible with the above description. In the XR EDMD patient
(case 1), contractures of the Achilles tendon and the elbows
were prominent without evident muscle wasting. However,
AD EDMD2 (case 2) showed severe muscle wasting, difficulty
in walking and joint contractures. In LGMD1B (case 3), the
predominant feature is a weakness of hip girdle muscle and
shoulder girdle muscles. Ankle contractures started later and
milder compared with cases of EDMD.
Cardiac involvement in EDMD may occur at any age or
may even be present at every onset, while on the other hand,
neuromuscular symptoms precede cardiological symptoms
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Fig. 6. The histopathologic findings of skeletal muscle biopsy specimen in AD EDMD2 (A) and LGMD1B (B-D) patient. (A) Myofibers are
reduced in number and replaced by fibroadipose tissues. There are atrophic or hypertrophic myofibers, internalization of sarcolemmal nuclei
and fiber splitting (hematoxylin and eosin stain, ×200). (B) Variation in myofiber size, frequent internal nuclei and fatty ingrowth are noted in
hematoxylin and eosin stain (×200). (C) ATPase pH 4.6 stain reveals atrophy of type 1 fibers (dark brown stain, ×200). (D) ATPase pH 9.4
stain reveals a predominance of type 2 fibers (brown stain, ×100).
A B
C Din nearly all patients with LGMD1B (15).
The cardiac conduction defect is the most serious and life
threatening clinical manifestation of the disease and is con-
sidered to be a hallmark of cardiomyopathy of EDMD. ECG
in the early findings shows sinus bradycardia, small P-wave
and prolonged P-R interval. According to the progress of dis-
ease, ECG shows atrial fibrillation or flutter, complete AV
block with idioventricular rhythm and atrial paralysis (atrial
standstill) (14). The documentation of the absence of electri-
cal atrial activity and inability to pace the atria by electrocar-
diogram and electrophysiological study in a patient with atrial
paralysis, is recognized as a pathognomonic finding of EDMD
(16). The normal myocardium is progressively replaced by
fibroadipose tissue (17), which results in atrial paralysis by
loss of atrial contractility and heart failure by atrial and ven-
tricular dilatation. Carriers are also at risk of cardiac arrhyth-
mias and sudden death (17). Patients with LGMD1B show
similar cardiological abnormalities to those of EDMD. They
include conduction disturbances and dysrythmias, present-
ing as an AV block, atrial fibrillation with high degree AV
block and junctional escape rhythm, bradycardia, atrial stand-
still and syncopal attacks. AV conduction disturbances in-
creased with age in LGMD1B patients and became more
severe (15). The potential complications of the cardiac pathol-
ogy in EDMD and LGMD1B include syncope, cerebral and
pulmonary emboli, congestive heart failure, cor pulmonale,
and sudden cardiac death, which may occur in the early twen-
ties (18).
In our study, the manifestations of cardiac involvement
were similar to those of reported cases. Atrial standstill was
noted in patients with EDMD and LGMD1B. The patient
with LGMD1B had a history of syncope and cerebral throm-
boembolism. The patient with LGMD1B showed findings
of dilated cardiomyopathy. However, in patients with EDMD,
the left ventricular function was preserved. All three patients
had severe bradycardia due to either conduction defects, atrial
tachycardia with high grade AV block, atrial fibrillation, and
sinus arrest with junctional escape rhythm.
Merlini et al. (19) reviewed 73 cases of XR EDMD from
six families, and showed that 30 patients died suddenly bet-
ween the age of 25 and 59 yr. Among them, only four patients
had minor symptoms with dizziness or syncopal episodes,
therefore, they ascertained that sudden death due to EDMD
was unpredictable in most cases. Consequently, a very impor-
tant aspect of management of EDMD and LGMD1B was
determined to be the early detection of cardiac conduction
defects. The insertion of a pacemaker may then be life saving.
In our cases, all patients were implanted with pacemakers.
However, these patients had not been diagnosed before, even
though they were consulted to cardiologists for rhythm dis-
turbances in other hospitals.
Based on the experience of our cases, we propose that screen-
ing for mutations in the emerin or lamin gene should be con-
sidered in patients with severe conduction defects and/or dilat-
ed cardiomyopathy. Vohanka et al. (20) reported that screen-
ing for mutations in the XR EDMD gene was performed
among 450 patients affected with severe heart rhythm defects
and/or dilated cardiomyopathy, and XR EDMD was found
among ten patients. Therefore, investigators should be con-
cerned about the genetic association of severe cardiac involve-
ment even in patients without muscular symptoms.
In conclusion, EDMD and LGMD1B are characterized by
slowly progressive skeletal myopathy and contractures of neck,
elbows and ankles, cardiac dysrhythmia, and late-onset car-
diomyopathy. Cardiac dysrhythmias in EDMD and LGMD1B
include AV block, bradycardia, atrial fibrillation, sinus arrest
and characteristic atrial standstill, causing syncope and sudden
cardiac death necessitating pacemaker implantation. Because
these patients are commonly undiagnosed, cardiologists should
be aware of these unusual genetic diseases as causes of conduc-
tion defects, especially in young adults.
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